New shot aims to stop dangerous leaks after pancreas surgery
NCT ID NCT07479784
Summary
This study is testing whether an injectable medication called octreotide microspheres can prevent a serious complication called pancreatic fistula after surgery to remove part of the pancreas. About 230 patients scheduled for this specific pancreas surgery will be randomly assigned to receive either the real medication or a placebo (dummy shot). The main goal is to see if the medication safely reduces the rate of these dangerous internal leaks in the 60 days after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC FISTULA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.